News
The success of suzetrigine supports the goal of moving beyond relieving pain to doing so safely, without perpetuating cycles ...
Dr. Reddy and Dr. Fuhrman from NexGenEsis Healthcare share how regenerative treatments help relieve pain without surgery or medication.
(CNN) — The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a prescription pill that ...
Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.
Editor’s Note (1/31/25): The U.S. Food and Drug Administration has approved the novel nonopioid medication suzetrigine for acute pain. That pain ranges from moderate to severe. The drug was ...
Hundreds of millions of people around the world experience chronic pain – meaning pain that lasts longer than three months. While the numbers vary from country to country, most studies estimate that ...
These observations underline that the treatment of neuropathic pain is still an unmet medical need. New approaches to the pharmacotherapy of neuropathy embrace different lines of work, including a ...
A phenomenon largely ignored since its discovery 100 years ago appears to be a crucial component of diabetic pain, according to new research from The University of Texas at Dallas's Center for ...
These mice lack a gene called SPARC, causing early spinal deterioration, inflammation, and chronic pain. Researchers administered two drugs to these mice: o-vanillin, a natural compound extracted ...
MIRA Pharmaceuticals stock rises as new preclinical data reveal its oral ketamine analog Ketamir-2 is 60% more effective than gabapentin in pain relief.
Dr. Reddy and Dr. Fuhrman from NexGenEsis Healthcare share how regenerative treatments help relieve pain without surgery or medication. To stream KHOU 11 on your phone, you need the KHOU 11 app ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results